Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2015/10/006289
CTRI/2015/10/006289CompletedPhase 3

To compare the efficacy of ormeloxifene versus oral contraceptive pills in medical management of menorrhagia due to uterine myomas

All India institute of medical Sciences New Delhi0 sites50 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
50
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Patients presenting with menorrhagia due to uterine myomas with intramural or subserosal myomas on ultrasound or submucosal grade 2 myomas on hysteroscopy

Exclusion Criteria

  • •Patients with more than 16 weeks gravid size uterus, submucosal myomas of grade 0 or 1 on hysteroscopy, atypia on endometrial histopathology, concurrent ovarian pathology, history or currently suffering from thromboembolic disease, smokers more than 35 years age, hypertension or with history of taking hormonal treatment within 3 months of treatment initiation

Investigators

Sponsor
All India institute of medical Sciences New Delhi

Similar Trials

Not yet recruiting
Not Applicable
Comparing Ormeloxifene With Norethisterone In Treatment For Uterine Bleeding Without Any Organic Cause
CTRI/2020/06/025630Dr Manogna Chukka
Not yet recruiting
Phase 4
Comparative Study Between Ormeloxifene And Norethisterone In The Management Of Patients Having Dysfunctional Uterine Bleeding : Prospective Randomized Study
CTRI/2019/08/020648Shri Sathya Sai Medical College And Research Institute
Not yet recruiting
Not Applicable
Ormeloxifene: a better therapeutic option than Medroxyprogesterone Acetate in perimenopausal women with abnormal uterine bleeding.
CTRI/2019/09/021275ivedita Chawla
Not yet recruiting
Phase 4
A study to find best medicine and its dose for the treatment of breast pain.
CTRI/2018/02/012043HLL lifecare Ltd
Recruiting
Phase 4
To compare the effects of two medicines in the amount of heavy menstrual bleeding and abdominal pain in women with uterine fibroid and adenomyosis
CTRI/2023/11/060283Department of Obstetrics and gynaecology